These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 19884012

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics.
    Cheng K, Zheng QZ, Hou J, Zhou Y, Liu CH, Zhao J, Zhu HL.
    Bioorg Med Chem; 2010 Apr 01; 18(7):2447-55. PubMed ID: 20304657
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
    Lv PC, Wang KR, Yang Y, Mao WJ, Chen J, Xiong J, Zhu HL.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6750-4. PubMed ID: 19836235
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K, Chu S.
    J Med Chem; 2005 Mar 10; 48(5):1596-609. PubMed ID: 15743201
    [Abstract] [Full Text] [Related]

  • 8. Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics.
    Lee JY, Jeong KW, Lee JU, Kang DI, Kim Y.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1506-13. PubMed ID: 19185501
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
    Li ZL, Li QS, Zhang HJ, Hu Y, Zhu DD, Zhu HL.
    Bioorg Med Chem; 2011 Aug 01; 19(15):4413-20. PubMed ID: 21752655
    [Abstract] [Full Text] [Related]

  • 10. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
    Zhou Y, Du QR, Sun J, Li JR, Fang F, Li DD, Qian Y, Gong HB, Zhao J, Zhu HL.
    ChemMedChem; 2013 Mar 01; 8(3):433-41. PubMed ID: 23401291
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
    Cheng K, Xue JY, Zhu HL.
    Bioorg Med Chem Lett; 2013 Jul 15; 23(14):4235-8. PubMed ID: 23731945
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F, Wen Q, Wang SF, Shahla Karim B, Yang YS, Liu JJ, Zhang WM, Zhu HL.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):90-5. PubMed ID: 24332628
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
    Li HQ, Shi L, Li QS, Liu PG, Luo Y, Zhao J, Zhu HL.
    Bioorg Med Chem; 2009 Sep 01; 17(17):6264-9. PubMed ID: 19664929
    [Abstract] [Full Text] [Related]

  • 15. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Li HQ, Luo Y, Zhu HL.
    Bioorg Med Chem; 2011 Aug 01; 19(15):4454-9. PubMed ID: 21742506
    [Abstract] [Full Text] [Related]

  • 16. Some biologically active oxovanadium(IV) complexes of triazole derived Schiff bases: their synthesis, characterization and biological properties.
    Chohan ZH, Sumrra SH.
    J Enzyme Inhib Med Chem; 2010 Oct 01; 25(5):599-607. PubMed ID: 20429776
    [Abstract] [Full Text] [Related]

  • 17. Novel depsides as potential anti-inflammatory agents with potent inhibitory activity against Escherichia coli-induced interleukin-8 production.
    Lv PC, Xiong J, Chen J, Wang KR, Mao WJ, Zhu HL.
    J Enzyme Inhib Med Chem; 2010 Aug 01; 25(4):590-5. PubMed ID: 20235754
    [Abstract] [Full Text] [Related]

  • 18. Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y, Yang YS, Song XD, Lu L, Zhu HL.
    Chem Pharm Bull (Tokyo); 2017 Aug 01; 65(2):178-185. PubMed ID: 28154310
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and antibacterial evaluation of 1beta-methyl-2-[5-(1-methoxyimino-2-substituted sulfonamide ethyl)pyrrolidin-3-ylthio]carbapenems and their related compounds.
    Jeon H, Jo NH, Yoo KH, Choi JH, Cho H, Cho JH, Oh CH.
    Eur J Med Chem; 2007 Mar 01; 42(3):358-64. PubMed ID: 17156896
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, characterization, EXAFS investigation and antibacterial activities of new ruthenium(III) complexes containing tetradentate Schiff base.
    Prabhakaran R, Geetha A, Thilagavathi M, Karvembu R, Krishnan V, Bertagnolli H, Natarajan K.
    J Inorg Biochem; 2004 Dec 01; 98(12):2131-40. PubMed ID: 15541503
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.